Search results for "Phosphodiesterase Inhibitors"

showing 10 items of 65 documents

Phosphodiesterase inhibitors suppress alpha2-adrenoceptor-mediated 5-hydroxytryptamine release from tracheae of newborn rabbits.

1998

The outflow of 5-hydroxytryptamine (5-HT) from isolated tracheae of newborn rabbits was determined by high pressure liquid chromatography with electrochemical detection. This 5-HT outflow reflects release from neuroendocrine epithelial cells of the airway mucosa, as previously shown. Phenylephrine, via alpha2B-adrenoceptors, caused a transient increase in 5-HT outflow, maximally by about 250%, an effect mediated by liberation of intracellular Ca2+, as previously shown. The non-selective phosphodiesterase inhibitor 2-isobutyl-1-methylxanthine (IBMX) concentration-dependently inhibited phenylephrine-induced 5-HT release (completely at 100 microM, IC50: 1.3 microM). Likewise, benzafentrine (in…

Malemedicine.medical_specialtySerotoninIBMXSiguazodanPhosphodiesterase InhibitorsPhosphodiesterase 3BiologyEpitheliumchemistry.chemical_compoundCyclic nucleotidePhenylephrineInternal medicine1-Methyl-3-isobutylxanthineQuinoxalinesmedicineAnimalsPhosphodiesterase inhibitorEnzyme InhibitorsPhenylephrineRolipramPharmacologyOxadiazolesPhosphodiesteraseTracheaEndocrinologychemistryAnimals NewbornFemaleRabbitsReceptors Adrenergic beta-2Adrenergic alpha-Agonistsmedicine.drugEuropean journal of pharmacology
researchProduct

Quality of partnership in patients with erectile dysfunction after sildenafil treatment.

2001

OBJECTIVE A comprehensive investigation on the quality of partnership of male patients with erectile dysfunction (ED) after treatment with sildenafil vs. untreated patients, as perceived by both the patients and their female partners. METHODS This report describes an observational, cross-sectional exploratory study comparing ED patients responsive to sildenafil with ED patients prior to therapy. Assessments included the 'International Index of Erectile Function' (IIEF) and the 'Partnerschaftsfragebogen' (PFB), a partnership questionnaire used in German-speaking countries. The comparability of the two study groups was examined using a stepwise logit model. Significant intergroup differences …

Malemedicine.medical_specialtySildenafilPhosphodiesterase InhibitorsLogistic regressionPiperazinesSildenafil Citratechemistry.chemical_compoundQuality of lifeErectile DysfunctionInternal medicineSurveys and QuestionnairesmedicineHumansPharmacology (medical)SulfonesMarriageGynecologybusiness.industryConfoundingGeneral MedicineMiddle Agedmedicine.diseaseTendernessPsychiatry and Mental healthSexual intercourseErectile dysfunctionCross-Sectional StudieschemistryPurinesObservational studyFemalemedicine.symptombusinessPharmacopsychiatry
researchProduct

Mechanism of the cardiovascular activity of laudanosine: comparison with papaverine and other benzylisoquinolines.

1994

1. The activity of (+/-)-laudanosine, a benzyltetrahydroisoquinoline alkaloid, was investigated in pithed rats and rat isolated aorta. Its effects on [3H]-(+)-cis-diltiazem and [3H]-nitrendipine binding to rat cerebral cortical membranes, and on the different molecular forms of cyclic nucleotide phosphodiesterases (PDE) isolated from bovine aorta were investigated. 2. The dose-response curve to methoxamine (3-300 micrograms kg-1, i.v.) in normotensive pithed rats was shifted to the right by (+/-)-laudanosine, 3 and 6 mg kg-1. 3. (+/-)-Laudanosine inhibited in a concentration-dependent manner the contractile responses evoked by noradrenaline (NA 1 microM), depolarizing solution (KCl 80 mM) o…

Malemedicine.medical_specialtyVascular smooth musclePhosphodiesterase InhibitorsAorta ThoracicPharmacologyIn Vitro TechniquesBinding CompetitiveMethoxamineMuscle Smooth VascularLaudanosinechemistry.chemical_compoundNorepinephrineRadioligand AssayInternal medicinePapaverinemedicineAnimalsRats WistarBenzylisoquinolinePharmacologyDecerebrate StatePapaverineChemistryAlkaloidHemodynamicsPhosphodiesteraseIsoquinolinesRatsEndocrinologyMechanism of actionCalciumCattlemedicine.symptommedicine.drugMuscle ContractionResearch ArticleBritish journal of pharmacology
researchProduct

Silica-coated calcium pectinate beads for colonic drug delivery

2013

The aim of this work is to develop novel organic-inorganic hybrid beads for colonic drug delivery. For this purpose, calcium pectinate beads with theophylline are prepared by a cross-linking reaction between amidated low-methoxyl pectin and calcium ions. The beads are then covered with silica, starting from tetraethyoxysilane (TEOS), by a sol-gel process. The influence of TEOS concentration (0.25, 0.50, 0.75 and 1.00 M) during the process is studied in order to modulate the thickness of the silica layer around the pectinate beads and thus to control the drug release. The interactions between the silica coating and the organic beads are weak according to the physicochemical characterizations…

Materials sciencefood.ingredientPectinColonPhosphodiesterase InhibitorsBiomedical Engineeringchemistry.chemical_elementCalciumBiochemistryCalcium pectinateDiffusionBiomaterialsfoodCoated Materials BiocompatibleNanocapsulesTheophyllineMaterials TestingmedicineAnimalsHumansTheophyllineMolecular BiologyDissolutionChromatographyGeneral MedicineSilicon DioxideControlled releaseGastrointestinal ContentsChemical engineeringchemistryDrug deliveryPectinsLayer (electronics)Biotechnologymedicine.drugActa Biomaterialia
researchProduct

Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications

2015

Abstract Systolic and diastolic myocardial dysfunction has been demonstrated to be associated with an activation of the circulating and local renin–angiotensin–aldosterone system (RAAS), and with a subsequent inappropriately increased production of reactive oxygen species (ROS). While, at low concentrations, ROS modulate important physiological functions through changes in cellular signalling and gene expression, overproduction of ROS may adversely alter cardiac mechanics, leading to further worsening of systolic and diastolic function. In addition, vascular endothelial dysfunction due to uncoupling of the nitric oxide synthase, activation of vascular and phagocytic membrane oxidases or mit…

Mitochondrial ROSmedicine.medical_specialtyXanthine OxidasePhosphodiesterase InhibitorsDiastoleAngiotensin-Converting Enzyme InhibitorsReviewmedicine.disease_causeNitric OxideCardiovascular SystemAntioxidantsInternal medicinemedicineHumansEndothelial dysfunctionHeart Failure DiastolicEjection fractionNitratesbusiness.industryDiastolic heart failureNADPH OxidasesStroke VolumeVitaminsHydralazinemedicine.diseaseHydralazineExercise TherapyMitochondriaOxidative StressHeart failureCardiologyDrug Therapy CombinationNitric Oxide SynthaseCardiology and Cardiovascular MedicinebusinessReactive Oxygen SpeciesOxidative stressmedicine.drugHeart Failure Systolic
researchProduct

Pharmacological and biochemical study on the effects of selective phosphodiesterase inhibitors on human term myometrium

1999

This study was aimed at evaluating the in vitro effects of phosphodiesterase inhibitors and beta2-adrenoceptor agonists on spontaneous contractions of human term myometrium. Rolipram, RP 73401 (3-cyclopentyloxy-N-(3,5(-dichloro-4-pyridil)-4-methoxybenzamide) and Ro 20-1724 (1-4-(3-butoxy-4-methoxybenzyl)-2-imidozolidinone) (phosphodiesterase 4 inhibitors) inhibited spontaneous myometrial contractions (Emax approximately 100%; pD2 of 6.80+/-0.28, 6.84+/-0.32 and 6.31+/-0.03, respectively). Salbutamol and formoterol were less effective (Emax=40+/-6% and 35+/-12%, respectively) than phosphodiesterase 4 inhibitors to reduce myometrial contractility. Inhibitors of phosphodiesterase 3 (milrinone …

Nitroprussidemedicine.medical_specialtyTocolytic agentPhosphodiesterase InhibitorsSiguazodanPhosphodiesterase 3In Vitro Techniqueschemistry.chemical_compoundPregnancyInternal medicinemedicineHumansDrug InteractionsRolipramPharmacologyChromatographyDose-Response Relationship DrugPhosphoric Diester HydrolasesPhosphodiesteraseGeneral MedicineAdrenergic beta-AgonistsIsoenzymesEndocrinologychemistryMyometriumMilrinoneFemaleSodium nitroprussideZaprinastmedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Evaluation of alprazolam-induced behavioural effects: differences with chlordiazepoxide after interaction with desipramine and rolipram, a cAMP phosp…

1989

PharmacologyMaleAlprazolamBehavior Animalbusiness.industryPhosphodiesterase InhibitorsDesipraminePhosphodiesteraseCAMP phosphodiesterase inhibitorChlordiazepoxideRats Inbred StrainsPharmacologyPyrrolidinonesChlordiazepoxideRatsAlprazolamDesipramineAnesthesiaMedicineAnimalsDrug InteractionsbusinessRolipramRoliprammedicine.drugPharmacological research
researchProduct

Cardiovascular effects induced by rolipram, a selective cAMP phosphodiesterase inhibitor: Interaction with adrenergic and calcium affecting drugs

1990

PharmacologyPhosphodiesterase InhibitorsHemodynamicschemistry.chemical_elementAdrenergicCAMP phosphodiesterase inhibitorCalciumPharmacologyCalcium Channel BlockersPyrrolidinonesCalcium Channel Agonistschemistry3'5'-Cyclic-AMP PhosphodiesterasesmedicineAnimalsRabbitsSympathomimeticsRolipramRoliprammedicine.drugPharmacological Research
researchProduct

Fragment- and negative image-based screening of phosphodiesterase 10A inhibitors.

2019

A novel virtual screening methodology called fragment- and negative image-based (F-NiB) screening is introduced and tested experimentally using phosphodiesterase 10A (PDE10A) as a case study. Potent PDE10A-specific small-molecule inhibitors are actively sought after for their antipsychotic and neuroprotective effects. The F-NiB combines features from both fragment-based drug discovery and negative image-based (NIB) screening methodologies to facilitate rational drug discovery. The selected structural parts of protein-bound ligand(s) are seamlessly combined with the negative image of the target's ligand-binding cavity. This cavity- and fragment-based hybrid model, namely its shape and electr…

PharmacologyVirtual screening010405 organic chemistryDrug discoveryChemistryPhosphodiesterase InhibitorsPhosphoric Diester HydrolasesOrganic ChemistryFragment-based lead discoveryAb initioDrug Evaluation PreclinicalPhosphodiesteraseComputational biology01 natural sciencesBiochemistrySmall molecule0104 chemical sciencesMolecular Docking Simulation010404 medicinal & biomolecular chemistryDocking (molecular)Drug DiscoveryMolecular MedicineHumansPharmacophoreChemical biologydrug designREFERENCES
researchProduct

Role of Redox Signaling, Protein Phosphatases and Histone Acetylation in the Inflammatory Cascade in Acute Pancreatitis: Therapeutic Implications

2010

Acute pancreatitis starts as a local inflammation of the pancreatic tissue but often leads to the systemic inflammatory response syndrome and death by multiple organ failure. Pro-inflammatory cytokines, particularly TNF-alpha and Il-1beta, play a pivotal role together with oxidative stress and glutathione depletion in the inflammatory response in this disease. Most inflammatory mediators act through mitogen activated protein kinases and nuclear factor kB. Nevertheless, elucidation of the precise mechanisms involved in activation and attenuation phases of the inflammatory cascade is still underway. Redox signaling mediated by inactivation of protein phosphatases and histone acetylation trigg…

Phosphodiesterase InhibitorsImmunologyPhosphataseBiologyHistonesDual-specificity phosphatasePhosphoprotein PhosphatasesHumansImmunology and AllergyPancreasHistone AcetyltransferasesInflammationPharmacologyHistone AcetyltransferasesKinaseAcetylationGeneral MedicineProtein phosphatase 2ChromatinCell biologyHistone Deacetylase InhibitorsHistonePancreatitisBiochemistryAcetylationAcute Diseasebiology.proteinSignal transductionOxidation-ReductionSignal TransductionInflammation & Allergy - Drug Targets
researchProduct